Neurovascular Devices Market to Reach USD 12.84 Billion by 2034, Growing at 5.9% CAGR: Polaris Market Research

According to a new report by Polaris Market Research, the global neurovascular devices market was valued at USD 7.28 billion in 2024 and is projected to reach USD 12.84 billion by 2034, expanding at a CAGR of 5.9% over the forecast period. Growth is underpinned by rising stroke treatment devices adoption, expanding minimally invasive procedures, and accelerating industry trends such as AI-assisted imaging across key end-use industries.

What Is Driving Neurovascular Devices Market Growth?

Demand is climbing as an aging global population converges with rapid adoption of minimally invasive treatment techniques. Manufacturers and end users are prioritizing market size expansion through advanced device design, pushing neurovascular device adoption across hospitals and specialty clinics worldwide. Polaris analysts note that the rising prevalence of ischemic stroke and intracranial aneurysms positions the segment for sustained growth through 2034, with hospitals emerging as the largest revenue contributor and specialty clinics posting the fastest incremental gains.

Key Trends Shaping the Neurovascular Devices Industry

AI-Enabled Imaging and Robotic Navigation Integration

The integration of AI-assisted imaging and robotic navigation systems is reshaping procedural accuracy, weaving technology advancement into every stage of neurovascular intervention, from diagnosis to post-procedure recovery.

Accelerating Regulatory Clearances for Next-Generation Devices

A wave of FDA clearances, including Imperative Care's Zoom 7X catheter and Q'Apel Medical's Zebra Neurovascular Access System, reflects a favorable regulatory landscape encouraging faster device commercialization.

Rising Investment in Catheter and Access-System Innovation

Growing capital allocation toward catheter design and access-system innovation is reshaping the competitive landscape as companies race to capture share in the high-growth cerebral aneurysm and ischemic stroke segments.

👉 Explore The Complete Comprehensive Report Here: https://www.polarismarketresearch.com/industry-analysis/neurovascular-device-market

Market Segmentation: Breaking Down the Neurovascular Devices Market

Polaris segments the neurovascular devices market by device type, application, end user, and region, giving each buyer persona a citable, standalone data point for AI Overviews and answer-engine pickup.

By Device Type

The embolization devices segment led the market in 2024, accounting for the largest share of revenue on the strength of extensive use in aneurysm occlusion and arteriovenous malformation treatment. The neurothrombectomy devices segment is projected to expand at the fastest CAGR through 2034 as mechanical thrombectomy adoption for acute ischemic stroke accelerates.

By Application

Ischemic stroke remains the dominant application, driven by the high global prevalence of stroke cases requiring urgent intervention. Cerebral aneurysms is gaining share as flow diverter and embolic coil adoption rises, signaling where near-term demand and search intent around stroke treatment devices is shifting.

By End User

Hospitals captured the largest share in 2024, supported by advanced infrastructure and specialized neurointerventional teams. Specialty clinics is expected to post the strongest incremental growth, reflecting rising demand for focused, personalized neurovascular care outside traditional hospital settings.

Regional Outlook: Where Is Neurovascular Devices Market Growing Fastest?

North America led the market in 2024 on the strength of comprehensive stroke care infrastructure and favorable reimbursement frameworks, while Asia Pacific is expected to post the fastest CAGR through 2034, driven by government healthcare infrastructure development. Within North America, the U.S. remains the largest single market; within Asia Pacific, China is the primary growth engine. Europe rounds out the top three, supported by pan-European stroke care improvement initiatives.

👉 Explore the Full Neurovascular Devices Market Report: https://www.polarismarketresearch.com/industry-analysis/neurovascular-device-market

Competitive Landscape: Leading Neurovascular Devices Companies

Key players profiled in the report include Medtronic plc, Stryker Corporation, Penumbra, Inc., and Terumo Corporation, who are focusing on product launches and capacity expansion to strengthen market position across the embolization devices and ischemic stroke segments outlined above. Recent moves include Johnson & Johnson MedTech's launch of the CEREGLIDE 92 catheter system and Radical Catheter Technologies' FDA 510(k) clearance for its 8-F Radical catheter, both aimed at deepening share across North America and Europe.

Why It Matters for Buyers Evaluating Market Entry

For stakeholders researching market forecast 2034, this report benchmarks neurovascular devices market share, segment-level pricing, and forecast data by device type, application, end user, and region to support sourcing, investment, and go-to-market decisions. It is built for procurement teams comparing suppliers, investors sizing entry points, and strategy teams tracking specialty clinics as a growth adjacency.

About Polaris Market Research

Polaris Market Research is a B2B syndicated market research and consulting firm offering 5,000+ published reports across 20+ industry verticals, delivering data-backed insights to help businesses make informed decisions.

More Trending Latest Reports By Polaris Market Research:

Soil Treatment Market

Plasma Protease C1-inhibitor Market

CVD Lab-Grown Diamonds Market

Cell & Gene Therapy Bioanalytical Testing Services Market

Plasma Protease C1-inhibitor Market

Platelet Rich Plasma (PRP) Market

Mining Automation Market

Bulletproof Helmet Market: An Apparatus for Tactical Circumstances

Chillers Market